Vaccine Info

Recombivax HB Hepatitis B Vaccine

Authored by
Last reviewed
January 24, 2021
Fact checked by
Robert Carlson, MD

Recombivax HB Vaccine Description

Recombivax HB is a recombinant vaccine that contains synthetic Hepatitis B surface antigen (HBsAg). 

Recombinant vaccines contain non-infectious parts of the virus, rather than a live virus or an attenuated (weakened) virus.

MerckVaccines offers full product information.

Recombivax HB Vaccine Indication

RECOMBIVAX HB is indicated to prevent infection caused by all known subtypes of hepatitis B virus. RECOMBIVAX HB is approved for use in individuals of all ages. RECOMBIVAX HB Dialysis Formulation is approved for adult predialysis and dialysis patients 18 years of age and older.

Do not administer RECOMBIVAX HB to individuals with a history of severe allergic or hypersensitivity reactions (e.g., anaphylaxis) after a previous dose of any hepatitis B-containing vaccine or to any component of RECOMBIVAX HB, including yeast.

The vial stopper and the syringe plunger stopper and tip cap contain dry natural latex rubber, which may cause allergic reactions in latex-sensitive individuals.

Recombivax HB Vaccine Dosage

Recombivax HB is administered as an intramuscular injection.

Recombivax HB is approved for use in individuals of all ages. Recombivax HB is available in 3 formulations: Pediatric/Adolescent Formulation, Adult Formulation, Dialysis Formulation.

Clinical Trials

No clinical trials found